Discover the full record of transactions filed by Robinson Chandler, 首席执行官. Insider active across 1 company, notably Monopar Therapeutics. Aggregated, 26 reports have been recorded. History available since 28 May 2024. The latest transaction was disclosed on 31 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Robinson Chandler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Robinson Chandler is Directeur Général and is linked to Monopar Therapeutics, where he is Chief Executive Officer. He has 26 filings in total, and in the sample of recent filings covering the period from 2021-07-02 to 2026-04-02, the most frequent transaction nature is Levée d'options. The buy and sell volumes shown for that sample are both EUR 0.